[{"Assets_0_Q2_USD":2397157000.0,"CommonStockSharesOutstanding_0_Q2_shares":212409152.0,"EarningsPerShareBasic_1_Q2_USD":0.25,"EarningsPerShareBasic_2_Q2_USD":0.05,"EarningsPerShareDiluted_1_Q2_USD":0.24,"EarningsPerShareDiluted_2_Q2_USD":0.05,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":53241000.0,"NetIncomeLoss_1_Q2_USD":52394000.0,"NetIncomeLoss_2_Q2_USD":11254000.0,"StockholdersEquity_0_Q2_USD":1732923000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":215103000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":215294000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":212210000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":211945000.0,"Ticker":"INCY","CIK":"879169","name":"INCYTE CORP","OfficialName":"Incyte Corp. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17588712770.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"SP500","filed":"20180731"}]